6127.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 May 2024 @ 04:08):

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally...

Stats
Today's Volume	2.10M
Average Volume	1.67M
Market Cap	12.77B
EPS	HKD0.270 ( 2024-01-10 )
Next earnings date	( HKD0.0300 ) 2024-06-07
Last Dividend	HKD0.440 ( 2023-06-20 )
Next Dividend	HKD0 ( N/A )
P/E	-105.56
ATR14	HKD0.00800 (0.08%)

Volume Correlation

Long: 0.08 (neutral)

Short: -0.36 (neutral)

Signal:(43.981) Neutral

Joinn Laboratories Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Joinn Laboratories Correlation - Currency/Commodity

0.15
( neutral )

0.38
( neutral )

0.00
( neutral )

0.75
( moderate )

-0.50
( neutral )

0.21
( neutral )

Joinn Laboratories Financials

Annual	2023
Revenue:	HKD2.38B
Gross Profit:	HKD1.01B (42.62 %)
EPS:	HKD0.530

FY	2023
Revenue:	HKD2.38B
Gross Profit:	HKD1.01B (42.62 %)
EPS:	HKD0.530

FY	2022
Revenue:	HKD2.27B
Gross Profit:	HKD1.09B (47.90 %)
EPS:	HKD2.01

FY	2021
Revenue:	HKD1.52B
Gross Profit:	HKD739.12M (48.73 %)
EPS:	HKD1.255

Financial Reports:

No articles found.

Joinn Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.420 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.440 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Joinn Laboratories Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.95 - low (64.35%) | Divividend Growth Potential Score: 0.247 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.214	2021-06-23
Last Dividend	HKD0.440	2023-06-20
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD1.074	--
Avg. Dividend % Per Year	0.00%	--
Score	1.31	--
Div. Sustainability Score	4.95
Div.Growth Potential Score	0.247
Div. Directional Score	2.60	--

Next Divdend (Est)
(2025-05-12)

HKD0.460 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

1.31

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6826.HK	Ex Dividend Knight	2023-07-04	Annually	0.00%
1930.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0954.HK	No Dividend Player	2023-05-22	Sporadic	0.00%
0064.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
3315.HK	Ex Dividend Knight	2023-05-30	Annually	0.00%
1522.HK	Ex Dividend Junior	2023-06-29	Sporadic	0.00%
0563.HK	Ex Dividend Junior	2023-05-24	Sporadic	0.00%
8635.HK	No Dividend Player	2023-08-02	Annually	0.00%
2096.HK	Ex Dividend Junior	2023-06-19	Annually	0.00%
1100.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0270	1.500	-0.540	-0.810	[0 - 0.5]
returnOnAssetsTTM	-0.00647	1.200	-0.216	-0.259	[0 - 0.3]
returnOnEquityTTM	-0.00775	1.500	-1.197	-1.796	[0.1 - 1]
payoutRatioTTM	-3.40	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	4.64	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.40	0.800	0.602	0.482	[0.8 - 2.5]
cashRatioTTM	1.907	1.500	0.517	0.775	[0.2 - 2]
debtRatioTTM	0.00652	-1.500	9.89	-10.00	[0 - 0.6]
interestCoverageTTM	2.46	1.000	-0.198	-0.198	[3 - 30]
operatingCashFlowPerShareTTM	1.000	2.00	9.67	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.741	2.00	9.63	10.00	[0 - 20]
debtEquityRatioTTM	0.00794	-1.500	9.97	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.398	1.000	6.70	6.70	[0.2 - 0.8]
operatingProfitMarginTTM	-0.000121	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	11.91	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.240	0.800	-1.736	-1.389	[0.5 - 2]
Total Score				4.95

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-107.54	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.00775	2.50	-0.770	-1.796	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.741	2.00	9.75	10.00	[0 - 30]
dividendYielPercentageTTM	5.35	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.000	2.00	9.67	10.00	[0 - 30]
payoutRatioTTM	-3.40	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	-1.677	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.324	1.000	4.39	0	[0.1 - 0.5]
Total Score				0.247

Joinn Laboratories

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.